Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome
- PMID: 20360470
- PMCID: PMC2892951
- DOI: 10.1182/blood-2010-01-263145
Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome
Abstract
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by childhood onset of lymphadenopathy, hepatosplenomegaly, autoimmune cytopenias, elevated numbers of double-negative T (DNT) cells, and increased risk of lymphoma. Most cases of ALPS are associated with germline mutations of the FAS gene (type Ia), whereas some cases have been noted to have a somatic mutation of FAS primarily in their DNT cells. We sought to determine the proportion of patients with somatic FAS mutations among a group of our ALPS patients with no detectable germline mutation and to further characterize them. We found more than one-third (12 of 31) of the patients tested had somatic FAS mutations, primarily involving the intracellular domain of FAS resulting in loss of normal FAS signaling. Similar to ALPS type Ia patients, the somatic ALPS patients had increased DNT cell numbers and elevated levels of serum vitamin B(12), interleukin-10, and sFAS-L. These data support testing for somatic FAS mutations in DNT cells from ALPS patients with no detectable germline mutation and a similar clinical and laboratory phenotype to that of ALPS type Ia. These findings also highlight the potential role for somatic mutations in the pathogenesis of nonmalignant and/or autoimmune hematologic conditions in adults and children.
Figures

Comment in
-
Somatic ALPS: a FAScinating condition.Blood. 2010 Jun 24;115(25):5125-6. doi: 10.1182/blood-2010-04-278465. Blood. 2010. PMID: 20576815 No abstract available.
-
Double-negative T cells are non-ALPS-specific markers of immune dysregulation found in patients with aplastic anemia.Blood. 2010 Dec 2;116(23):5072-3. doi: 10.1182/blood-2010-09-306910. Blood. 2010. PMID: 21127186 No abstract available.
Similar articles
-
Next Generation Sequencing for Detecting Somatic FAS Mutations in Patients With Autoimmune Lymphoproliferative Syndrome.Front Immunol. 2021 Apr 29;12:656356. doi: 10.3389/fimmu.2021.656356. eCollection 2021. Front Immunol. 2021. PMID: 33995372 Free PMC article.
-
A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.Blood. 2011 Nov 3;118(18):4798-807. doi: 10.1182/blood-2011-04-347641. Epub 2011 Sep 1. Blood. 2011. PMID: 21885602
-
Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.J Allergy Clin Immunol. 2024 Jan;153(1):297-308.e12. doi: 10.1016/j.jaci.2023.11.006. Epub 2023 Nov 17. J Allergy Clin Immunol. 2024. PMID: 37979702
-
Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.Pediatr Allergy Immunol. 2021 Oct;32(7):1519-1532. doi: 10.1111/pai.13535. Epub 2021 May 27. Pediatr Allergy Immunol. 2021. PMID: 33963613
-
The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.J Clin Immunol. 2018 Jul;38(5):558-568. doi: 10.1007/s10875-018-0523-x. Epub 2018 Jun 17. J Clin Immunol. 2018. PMID: 29911256 Review.
Cited by
-
Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.J Clin Invest. 2011 Jan;121(1):106-12. doi: 10.1172/JCI43752. Epub 2010 Dec 22. J Clin Invest. 2011. PMID: 21183795 Free PMC article.
-
Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).Clin Rev Allergy Immunol. 2016 Feb;50(1):55-63. doi: 10.1007/s12016-015-8466-y. Clin Rev Allergy Immunol. 2016. PMID: 25663566 Review.
-
NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression.J Biol Chem. 2012 Jul 20;287(30):25530-40. doi: 10.1074/jbc.M112.356279. Epub 2012 Jun 5. J Biol Chem. 2012. PMID: 22669972 Free PMC article.
-
Clues to immune tolerance: the monogenic autoimmune syndromes.Ann N Y Acad Sci. 2010 Dec;1214:138-55. doi: 10.1111/j.1749-6632.2010.05818.x. Epub 2010 Oct 22. Ann N Y Acad Sci. 2010. PMID: 20969580 Free PMC article. Review.
-
5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL+ Cytotoxic T Lymphocyte Cytotoxicity.Cancers (Basel). 2023 Mar 2;15(5):1563. doi: 10.3390/cancers15051563. Cancers (Basel). 2023. PMID: 36900354 Free PMC article.
References
-
- Sneller MC, Wang J, Dale JK, et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood. 1997;89(4):1341–1348. - PubMed
-
- Avila NA, Dwyer AJ, Dale JK, et al. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis—CT and US features. Radiology. 1999;212(1):257–263. - PubMed
-
- Lopatin U, Yao X, Williams RK, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood. 2001;97(10):3161–3170. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous